<DOC>
	<DOC>NCT00483808</DOC>
	<brief_summary>To investigate the clinical utility of renal denervation in the treatment of refractory hypertension.</brief_summary>
	<brief_title>Renal Denervation in Patients With Refractory Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>&gt;= 18 years of age. a systolic blood pressure of 160 mmHg or greater. receiving and adhering to full doses of an appropriate antihypertensive drug regimen for a minimum of two weeks prior to screening. agrees to have the study procedure(s) performed and additional procedures and evaluations, including repeat phlebotomy, imaging, urine analyses, and clinical examination. competent and willing to provide written, informed consent to participate in this clinical study. renal arterial abnormalities end stage renal disease requiring dialysis or renal transplant serum Cr &gt; 3, or calculated GFR &lt; 45 ml/min has experienced MI, unstable angina pectoris, or CVA with 6 months others</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>